Cargando…

PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism

Peroxisome proliferator activated receptor gamma 2 (PPARg2) is the nutritionally regulated isoform of PPARg. Ablation of PPARg2 in the ob/ob background, PPARg2(−/−) Lep(ob)/Lep(ob) (POKO mouse), resulted in decreased fat mass, severe insulin resistance, β-cell failure, and dyslipidaemia. Our results...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina-Gomez, Gema, Gray, Sarah L, Yetukuri, Laxman, Shimomura, Kenju, Virtue, Sam, Campbell, Mark, Curtis, R. Keira, Jimenez-Linan, Mercedes, Blount, Margaret, Yeo, Giles S. H, Lopez, Miguel, Seppänen-Laakso, Tuulikki, Ashcroft, Frances M, Orešič, Matej, Vidal-Puig, Antonio
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857730/
https://www.ncbi.nlm.nih.gov/pubmed/17465682
http://dx.doi.org/10.1371/journal.pgen.0030064
_version_ 1782133165007044608
author Medina-Gomez, Gema
Gray, Sarah L
Yetukuri, Laxman
Shimomura, Kenju
Virtue, Sam
Campbell, Mark
Curtis, R. Keira
Jimenez-Linan, Mercedes
Blount, Margaret
Yeo, Giles S. H
Lopez, Miguel
Seppänen-Laakso, Tuulikki
Ashcroft, Frances M
Orešič, Matej
Vidal-Puig, Antonio
author_facet Medina-Gomez, Gema
Gray, Sarah L
Yetukuri, Laxman
Shimomura, Kenju
Virtue, Sam
Campbell, Mark
Curtis, R. Keira
Jimenez-Linan, Mercedes
Blount, Margaret
Yeo, Giles S. H
Lopez, Miguel
Seppänen-Laakso, Tuulikki
Ashcroft, Frances M
Orešič, Matej
Vidal-Puig, Antonio
author_sort Medina-Gomez, Gema
collection PubMed
description Peroxisome proliferator activated receptor gamma 2 (PPARg2) is the nutritionally regulated isoform of PPARg. Ablation of PPARg2 in the ob/ob background, PPARg2(−/−) Lep(ob)/Lep(ob) (POKO mouse), resulted in decreased fat mass, severe insulin resistance, β-cell failure, and dyslipidaemia. Our results indicate that the PPARg2 isoform plays an important role, mediating adipose tissue expansion in response to positive energy balance. Lipidomic analyses suggest that PPARg2 plays an important antilipotoxic role when induced ectopically in liver and muscle by facilitating deposition of fat as relatively harmless triacylglycerol species and thus preventing accumulation of reactive lipid species. Our data also indicate that PPARg2 may be required for the β-cell hypertrophic adaptive response to insulin resistance. In summary, the PPARg2 isoform prevents lipotoxicity by (a) promoting adipose tissue expansion, (b) increasing the lipid-buffering capacity of peripheral organs, and (c) facilitating the adaptive proliferative response of β-cells to insulin resistance.
format Text
id pubmed-1857730
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-18577302007-04-27 PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism Medina-Gomez, Gema Gray, Sarah L Yetukuri, Laxman Shimomura, Kenju Virtue, Sam Campbell, Mark Curtis, R. Keira Jimenez-Linan, Mercedes Blount, Margaret Yeo, Giles S. H Lopez, Miguel Seppänen-Laakso, Tuulikki Ashcroft, Frances M Orešič, Matej Vidal-Puig, Antonio PLoS Genet Research Article Peroxisome proliferator activated receptor gamma 2 (PPARg2) is the nutritionally regulated isoform of PPARg. Ablation of PPARg2 in the ob/ob background, PPARg2(−/−) Lep(ob)/Lep(ob) (POKO mouse), resulted in decreased fat mass, severe insulin resistance, β-cell failure, and dyslipidaemia. Our results indicate that the PPARg2 isoform plays an important role, mediating adipose tissue expansion in response to positive energy balance. Lipidomic analyses suggest that PPARg2 plays an important antilipotoxic role when induced ectopically in liver and muscle by facilitating deposition of fat as relatively harmless triacylglycerol species and thus preventing accumulation of reactive lipid species. Our data also indicate that PPARg2 may be required for the β-cell hypertrophic adaptive response to insulin resistance. In summary, the PPARg2 isoform prevents lipotoxicity by (a) promoting adipose tissue expansion, (b) increasing the lipid-buffering capacity of peripheral organs, and (c) facilitating the adaptive proliferative response of β-cells to insulin resistance. Public Library of Science 2007-04 2007-04-27 /pmc/articles/PMC1857730/ /pubmed/17465682 http://dx.doi.org/10.1371/journal.pgen.0030064 Text en © 2007 Medina-Gomez et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Medina-Gomez, Gema
Gray, Sarah L
Yetukuri, Laxman
Shimomura, Kenju
Virtue, Sam
Campbell, Mark
Curtis, R. Keira
Jimenez-Linan, Mercedes
Blount, Margaret
Yeo, Giles S. H
Lopez, Miguel
Seppänen-Laakso, Tuulikki
Ashcroft, Frances M
Orešič, Matej
Vidal-Puig, Antonio
PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism
title PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism
title_full PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism
title_fullStr PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism
title_full_unstemmed PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism
title_short PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism
title_sort ppar gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857730/
https://www.ncbi.nlm.nih.gov/pubmed/17465682
http://dx.doi.org/10.1371/journal.pgen.0030064
work_keys_str_mv AT medinagomezgema ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT graysarahl ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT yetukurilaxman ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT shimomurakenju ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT virtuesam ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT campbellmark ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT curtisrkeira ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT jimenezlinanmercedes ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT blountmargaret ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT yeogilessh ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT lopezmiguel ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT seppanenlaaksotuulikki ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT ashcroftfrancesm ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT oresicmatej ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism
AT vidalpuigantonio ppargamma2preventslipotoxicitybycontrollingadiposetissueexpandabilityandperipherallipidmetabolism